Dietary supplement considerations during glucagon-like peptide-1 receptor agonist treatment: a narrative review
Regular follow-up appointments, typically scheduled every 4 to 12 weeks during the initial treatment phase, allow for dose adjustments, side effect management, and monitoring of therapeutic outcomes
The first few months represent an exceptional period, not the permanent pace
Some users report immediate relief from burping after taking famotidine
Detailed TRIUMPH-1 data is expected to be presented at the 86th American Diabetes Association Scientific Sessions later in 2026
Very low calorie diets below 800 calories daily should only be followed under medical supervision within a structured weight management programme, as unsupervised restriction can lead to nutritional deficiencies, muscle loss, gallstones, and electrolyte imbalances